Abbott Laboratories (ETR:ABL)
109.02
+1.60 (1.49%)
Nov 7, 2025, 5:35 PM CET
Abbott Laboratories Revenue
Abbott Laboratories had revenue of $11.37B USD in the quarter ending September 30, 2025, with 6.90% growth. This brings the company's revenue in the last twelve months to $43.84B, up 6.37% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.
Revenue (ttm)
$43.84B
Revenue Growth
+6.37%
P/S Ratio
5.08
Revenue / Employee
$384.59K
Employees
114,000
Market Cap
189.75B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.95B | 1.84B | 4.59% |
| Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
| Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
| Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
| Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.22B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Abbott Laboratories News
- 1 day ago - 10 Defensive Stocks with Market-Beating Yields - Barrons
- 2 days ago - Christine Poole's Top Picks: Abbott Labs, CN Rail & Otis Worldwide - BNN Bloomberg
- 8 days ago - Best Dividend Aristocrats For November 2025 - Seeking Alpha
- 10 days ago - Abbott Showcases World's First Dual Chamber Leadless Pacemaker in National Media Tour Featuring Patient Story with YourUpdateTV - GlobeNewsWire
- 11 days ago - Best Dividend Kings: October 2025 - Seeking Alpha
- 12 days ago - Is the Market Bullish or Bearish on Abbott Laboratories? - Benzinga
- 18 days ago - A Look Into Abbott Laboratories Inc's Price Over Earnings - Benzinga
- 18 days ago - Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock - Nasdaq